Body

Novel bioreactor enhances interleukin-12 production in genetically-modified tobacco plants

WORCESTER, Mass. – Dec. 3, 2008 – Interleukin-12 is a naturally occurring protein essential for the proper functioning of the human immune system. Having either too much or too little interleukin-12 may play a role in the development of many diseases, including some cancers and auto-immune disorders like Crohn's, psoriasis, and rheumatoid arthritis. In turn, modulating interleukin-12 levels could yield new therapies for those conditions.

International study supports new standard of treatment for women with advanced ovarian cancer

Louisville, Ky. – Results of a phase III, international randomized clinical trial demonstrate a new standard of care for treating advanced ovarian cancer that significantly reduces side-effects and post-operative deaths compared to the previously established treatment course. The study, presented at the 12th Biennial Meeting of the International Gynecologic Cancer Society (IGCS) in Bangkok in October, has a major impact on many countries where the new standard represents a more practical course of treatment.

Infants participate in complex interactions with their parents

St. Petersburg, FL – December 3, 2008 – A new study in the journal Family Process shows that infants appear to be active participants in complex interactional sequences with their parents far earlier than previously thought. Researchers documented the capacity of three-month old infants to share attention with two partners simultaneously.

Genetic breakdown in Fanconi anemia may have link to HPV-associated cancer

CINCINNATI – A genetic malfunction that causes DNA instability in people with the blood disorder Fanconi anemia may put them at high risk for squamous cell carcinomas linked to human papillomavirus (HPV), according to a study posted online ahead of print by Oncogene.

Some 70 percent of schoolchildren don't walk to school

Montreal, December 3, 2008 – Days when schoolchildren walked to neighbourhood schools are long gone. A new study by a team of researchers led by Paul Lewis, a professor of Urban Planning at the Université de Montréal, shows that only 30 percent of children attending elementary school reach school on foot or by bicycle.

The International Society for Stem Cell Research releases new guidelines

Deerfield, IL, December 3, 2008 – Today, the International Society for Stem Cell Research (ISSCR), the world's leading professional organization of stem cell researchers, released new guidelines for the responsible development of safe and effective stem cell therapies for patients. A Commentary article that summarizes the Guidelines for the Clinical Translation of Stem Cells will be published by Cell Press in the December issue of Cell Stem Cell, the official affiliated journal of the ISSCR.

Pregnant women with asthma can be more confident about some medicines

Budesonide sprays can be regarded as safe for pregnancy - other asthma drugs have not been as well studied though

Sleeping in school

Up to 10% of children starting school suffer from sleep disturbances and these may lead to poor performance or behavioral difficulties. In the current edition of Deutsches Ärzteblatt International (Dtsch Arztebl Int 2007; 105[47]: 809-14), the child and adolescent psychiatrist Gerd Lehmkuhl and his colleagues present the results of a study from Cologne, Germany.

WHO tool helps target bone treatment

Better targeted, more cost-effective osteoporosis treatment could soon be a reality worldwide. A new method (1) for determining more accurately at which point someone needs further diagnostic tests, or when immediate treatment is warranted, has been developed by The National Osteoporosis Guideline Group in the UK.

Statement from the ESC regarding the ongoing CT-scan vs. invasive angiography debate

Recent media reports based on a new study published in the New England Journal of Medicine (27 November 2008 issue) have announced that "noninvasive CT scans cannot replace imaging of coronary artery blockages by conventional invasive angiography".

In response, imaging specialist Professor Juhani Knuuti, spokesperson for the European Society of Cardiology and Past-Chair of the ESC Working Group on Nuclear Cardiology and Cardiac CT, emphasizes the following points.

New 'control knobs' for stem cells identified

MEDFORD/SOMERVILLE, Mass. – Natural changes in voltage that occur across the membrane of adult human stem cells are a powerful controlling factor in the process by which these stem cells differentiate, according to research published by Tufts University scientists.

Top-up system has hidden costs that have not been accounted for

London, UK, 03 December 2008 - The "cost" of top-up payments to the NHS are not confined to the cost of the drug and require the NHS to make some long overdue changes or risk financial failure, argue two editorials published in Clinical Oncology, by Elsevier.

New HIV film tackles stigma faced by teachers in Africa

Addressing the discrimination against HIV-positive teachers in Africa is a key aim of a new documentary and accompanying book being launched in Senegal today by the Partnership for Child Development based at Imperial College London.

Prostate cancer drug reduces testosterone levels in as little as 3 days

More than 95 per cent of men who took degarelix for prostate cancer saw their testosterone levels fall dramatically as early as three days after they started treatment, according to a paper in the December issue of BJU International.

They also experienced much greater falls in their prostate-specific antigen (PSA) levels at 14 and 28 days than men taking leuprolide.

Researchers from Canada, the USA, France, Denmark and the Netherlands studied 610 men as part of the Phase Three trial, randomly assigning them to one of three study groups.

Broccoli compound targets key enzyme in late-stage cancer

Berkeley -- An anti-cancer compound found in broccoli and cabbage works by lowering the activity of an enzyme associated with rapidly advancing breast cancer, according to a University of California, Berkeley, study appearing this week in the online early edition of the journal Proceedings of the National Academy of Sciences.

The compound, indole-3-carbinol, is already undergoing clinical trials in humans because it was found to stop the growth of breast and prostate cancer cells in mice.